# Neurogene (NGNE) — News

NGNE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ngne/news

## Recent headlines

- [CMA CGM - From 2029, this facility, developed by Engie, will supply 7,000 tonnes of biomethane (equivalent to 100 GWh) each year to the CMA CGM fleet](https://www.ainvest.com/news/cma-cgm-2029-facility-developed-engie-supply-7-000-tonnes-biomethane-equivalent-100-gwh-year-cma-cgm-fleet-2610) — AInvest Wire, Oct 13, 2026
  CMA CGM has announced a new initiative in its ongoing efforts to achieve carbon neutrality by 2050, with a facility developed by Engie set to supply 7,000 tonnes of biomethane annually, equivalent to 100 gigawatt-hours (GWh), to the CMA CGM fleet starting in 2029. This development aligns with the…
- [Prudential Financial Inc reports 11.2% passive stake in Neurogene as of Sept 30 - SEC filing](https://www.ainvest.com/news/prudential-financial-reports-11-2-passive-stake-neurogene-sept-30-sec-filing-2610) — AInvest Wire, Oct 7, 2026
  Prudential Financial Inc. has disclosed an 11.2% passive stake in Neurogene as of September 30, 2026, according to a recent SEC filing. The investment is categorized as a passive position, indicating that Prudential does not exercise significant influence over Neurogene’s operations or strategic…
- [Jennison Associates LLC reports 11.1% passive stake in Neurogene as of Sept 30 - SEC filing](https://www.ainvest.com/news/jennison-associates-llc-reports-11-1-passive-stake-neurogene-sept-30-sec-filing-2610) — AInvest Wire, Oct 6, 2026
  Jennison Associates LLC has disclosed a 11.1% passive stake in Neurogene as of September 30, according to a recent SEC filing[1]. The investment, which is categorized as a passive position, indicates a significant level of ownership without implying active management or control over the company’s…
- [Neurogene Inc: Canaccord Genuity cuts target price to $166 from $180](https://www.ainvest.com/news/neurogene-canaccord-genuity-cuts-target-price-166-180-2608) — AInvest Wire, Aug 11, 2026
- [Neurogene Q2 EPS USD -1.53 (removes extraneous word)](https://www.ainvest.com/news/neurogene-q2-eps-usd-1-53-removes-extraneous-word-2608) — AInvest Wire, Aug 11, 2026
  Neurogene Inc. (NASDAQ: NGNE) is expected to report its second-quarter 2026 earnings on August 7, 2026, with an estimated EPS of -1.42 USD . Analysts project a continuation of the company’s trend of negative earnings, with the EPS estimate for Q2 2026 slightly worse than the -1.39 USD reported in…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).